Skip to content

Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation

Do Anti-Snoring Appliances Reduce the Amount of Airway Manipulation in Patients Undergoing Anesthetic Sedation? A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05748626
Enrollment
25
Registered
2023-03-01
Start date
2023-03-06
Completion date
2023-10-24
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Obstruction, Sedation Complication, Snoring

Keywords

Airway obstruction, Snoring, Monitored Anesthesia Care, Intravenous sedation

Brief summary

Would patients using an anti-snoring appliance intraoperatively require less airway manipulation, interventions, and rescue maneuvers during anesthetic sedation cases compared to those who do not? The investigators will use anti-snoring appliance devices (specifically the FDA approved Zyppah) to attempt to relieve tissue obstructions that cause snoring during sleep. The application of the devices to the body is less invasive than other common intraoperative rescue airway devices (e.g. nasal trumpets and oral airways) which are not designed to be patient specific.

Interventions

DEVICEAnti-snoring device

For group 1, the study team will aid the subject in molding and preparing the device in the pre-operative area. They will wear the device throughout the entirety of the case.

PROCEDURENo anti -snoring device during their procedure.

For group 2 there will be no anti snoring device used during the case.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled interventional trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (age 18-89 years old) * Undergoing procedures below the umbilicus requiring anesthetic sedation without an invasive airway * a STOP-BANG (survey) score of 2 or greater.

Exclusion criteria

* Patients who are unable to consent * Non-English speaking * Those requiring general anesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Combined Total Number of Airway Interventions During an Anesthetic Sedation CaseThrough study completion, an average of 1 dayCombined total number of airway interventions during an anesthetic sedation case - including head tilt/rotation, mandible thrust, chin lift, shoulder lift, neck extension or flexion, tongue pull.

Secondary

MeasureTime frameDescription
Number of Instances SpO2 Value < 92%Through study completion, an average of 1 dayNumber of instances the SpO2 drops below 92% during the procedure
Minimum End-title CO2 in mmHgThrough study completion, an average of 1 dayMinimum end-tidal CO2 (capnography) using measures the partial pressure or maximal concentration of carbon dioxide (CO2) at the end of an exhaled breath, which is expressed as a percentage of CO2 or mmHg. The normal values are 5% to 6% CO2, which is equivalent to 35-45 mmHg.
Percent Time During the Case the SpO2 is Below 92%Through study completion, an average of 1 dayPercent time during the case the SpO2 is below 92% using pulse oximetry.
Maximum SpO2 Value During the CaseThrough study completion, an average of 1 dayMaximum SpO2 value during the case using pulse oximetry (percent saturated)
Minimum SpO2 Value During the CaseThrough study completion, an average of 1 dayMinimum SpO2 value during the case using pulse oximetry (percent saturation)
Heart Rate MaximumThrough study completion, an average of 1 dayMaximum heart rate during case using standard operating room cardiac monitor
Heart Rate MinimumThrough study completion, an average of 1 dayMinimum heart rate during case using standard operating room cardiac monitor
Maximum End-tidal CO2Through study completion, an average of 1 dayMaximum end-tidal CO2 using measures the partial pressure or maximal concentration of carbon dioxide (CO2) at the end of an exhaled breath, which is expressed as a percentage of CO2 or mmHg. The normal values are 5% to 6% CO2, which is equivalent to 35-45 mmHg.
Minimum Systolic Blood PressureThrough study completion, an average of 1 dayMinimum systolic blood pressure (mmHg) using standard operating room blood pressure cuff and monitor.
Maximum Diastolic Blood PressureThrough study completion, an average of 1 dayMaximum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.
Minimum Diastolic Blood PressureThrough study completion, an average of 1 dayMinimum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.
Minimum Mean Blood PressureThrough study completion, an average of 1 dayMean minimum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.
Maximum Mean Blood PressureThrough study completion, an average of 1 dayMaximum mean blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.
Reintubation in the Post Anesthesia Care Unit1 DayNumber of participants requiring reintubation with an endotracheal tube post surgery in the Post Anesthesia Care Unit
Surgical Length of Time1 daySurgical length of time in hours.
Maximum Systolic Blood PressureThrough study completion, an average of 1 dayMaximum systolic blood pressure (mmHg) using standard operating room blood pressure cuff and monitor.

Countries

United States

Participant flow

Participants by arm

ArmCount
Group #1: Anti-snoring Appliance
Group #1: Anti-snoring appliance (Zyppah) that will be utilized during their procedure. Anti-snoring device: For group 1, the study team will aid the subject in molding and preparing the device in the pre-operative area. They will wear the device throughout the entirety of the case.
12
Group #2: Control Group, That Will Not Utilize Anti-snoring Appliance
Group #2: Control group, that will not utilize (Zyppah) anti-snoring appliance during their procedure. No anti -snoring device during their procedure.: For group 2 there will be no anti snoring device used during the case.
13
Total25

Baseline characteristics

CharacteristicGroup #1: Anti-snoring ApplianceGroup #2: Control Group, That Will Not Utilize Anti-snoring ApplianceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants4 Participants11 Participants
Age, Categorical
Between 18 and 65 years
5 Participants9 Participants14 Participants
Age, Continuous66.5 Years63.2 Years64.8 Years
American Society of Anesthesiology Status
ASA 2 Status
9 Participants5 Participants14 Participants
American Society of Anesthesiology Status
ASA 3 Status
3 Participants8 Participants11 Participants
Body Mass Index31.8 (kg) / height (m)^2
STANDARD_DEVIATION 6.9
30.0 (kg) / height (m)^2
STANDARD_DEVIATION 5.2
30.88 (kg) / height (m)^2
STANDARD_DEVIATION 5.88
Documented Mallampati Score
Mallampati Score Class 1
2 Participants5 Participants7 Participants
Documented Mallampati Score
Mallampati Score Class 2
5 Participants4 Participants9 Participants
Documented Mallampati Score
Mallampati Score Class 3
4 Participants3 Participants7 Participants
Documented Mallampati Score
Mallampati Score Class 4
1 Participants1 Participants2 Participants
Documented Obstructive Sleep Apnea0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants13 Participants23 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Height (Inches)66.0 Inches
STANDARD_DEVIATION 4.2
68.1 Inches
STANDARD_DEVIATION 4
67 Inches
STANDARD_DEVIATION 4.5
Region of Enrollment
United States
12 participants13 participants25 participants
Sex: Female, Male
Female
6 Participants10 Participants16 Participants
Sex: Female, Male
Male
6 Participants3 Participants9 Participants
STOP Bang Score3.3 Score on Scale (0 low risk -8 high risk)
STANDARD_DEVIATION 0.8
3.0 Score on Scale (0 low risk -8 high risk)
STANDARD_DEVIATION 0.8
3.14 Score on Scale (0 low risk -8 high risk)
STANDARD_DEVIATION 0.8
Weight (Kilograms)89.3 Kilograms
STANDARD_DEVIATION 19.6
90 Kilograms
STANDARD_DEVIATION 18.3
89.6 Kilograms
STANDARD_DEVIATION 19.1

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 13
other
Total, other adverse events
1 / 120 / 13
serious
Total, serious adverse events
0 / 120 / 13

Outcome results

Primary

Combined Total Number of Airway Interventions During an Anesthetic Sedation Case

Combined total number of airway interventions during an anesthetic sedation case - including head tilt/rotation, mandible thrust, chin lift, shoulder lift, neck extension or flexion, tongue pull.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (NUMBER)
Group #1: Anti-snoring ApplianceCombined Total Number of Airway Interventions During an Anesthetic Sedation Case7 Airway Interventions
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceCombined Total Number of Airway Interventions During an Anesthetic Sedation Case5 Airway Interventions
Secondary

Heart Rate Maximum

Maximum heart rate during case using standard operating room cardiac monitor

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceHeart Rate Maximum80.8 Heart Rate (Beats Per Minute)Standard Deviation 14.3
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceHeart Rate Maximum82.5 Heart Rate (Beats Per Minute)Standard Deviation 15
Secondary

Heart Rate Minimum

Minimum heart rate during case using standard operating room cardiac monitor

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceHeart Rate Minimum53.4 Heart Rate (Beats Per Minute)Standard Deviation 6.5
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceHeart Rate Minimum58.5 Heart Rate (Beats Per Minute)Standard Deviation 11.1
Secondary

Maximum Diastolic Blood Pressure

Maximum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMaximum Diastolic Blood Pressure75.3 mmHGStandard Deviation 14.3
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMaximum Diastolic Blood Pressure77.1 mmHGStandard Deviation 8.7
Secondary

Maximum End-tidal CO2

Maximum end-tidal CO2 using measures the partial pressure or maximal concentration of carbon dioxide (CO2) at the end of an exhaled breath, which is expressed as a percentage of CO2 or mmHg. The normal values are 5% to 6% CO2, which is equivalent to 35-45 mmHg.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMaximum End-tidal CO241 mmHGStandard Deviation 9.4
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMaximum End-tidal CO244.4 mmHGStandard Deviation 5.5
Secondary

Maximum Mean Blood Pressure

Maximum mean blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMaximum Mean Blood Pressure98.4 mmHGStandard Deviation 12.5
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMaximum Mean Blood Pressure104.5 mmHGStandard Deviation 15.6
Secondary

Maximum SpO2 Value During the Case

Maximum SpO2 value during the case using pulse oximetry (percent saturated)

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMaximum SpO2 Value During the Case99.9 PercentStandard Deviation 0.3
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMaximum SpO2 Value During the Case99.5 PercentStandard Deviation 1.7
Secondary

Maximum Systolic Blood Pressure

Maximum systolic blood pressure (mmHg) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMaximum Systolic Blood Pressure140 mmHGStandard Deviation 16.9
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMaximum Systolic Blood Pressure152.2 mmHGStandard Deviation 21.7
Secondary

Minimum Diastolic Blood Pressure

Minimum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMinimum Diastolic Blood Pressure51.2 mmHGStandard Deviation 5.1
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMinimum Diastolic Blood Pressure53.2 mmHGStandard Deviation 14.7
Secondary

Minimum End-title CO2 in mmHg

Minimum end-tidal CO2 (capnography) using measures the partial pressure or maximal concentration of carbon dioxide (CO2) at the end of an exhaled breath, which is expressed as a percentage of CO2 or mmHg. The normal values are 5% to 6% CO2, which is equivalent to 35-45 mmHg.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMinimum End-title CO2 in mmHg7 mmHGStandard Deviation 7.4
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMinimum End-title CO2 in mmHg6.7 mmHGStandard Deviation 5
Secondary

Minimum Mean Blood Pressure

Mean minimum diastolic blood pressure (mmHG) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMinimum Mean Blood Pressure65.1 mmHGStandard Deviation 6.4
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMinimum Mean Blood Pressure64.6 mmHGStandard Deviation 9.2
Secondary

Minimum SpO2 Value During the Case

Minimum SpO2 value during the case using pulse oximetry (percent saturation)

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMinimum SpO2 Value During the Case91.3 PercentStandard Deviation 5.9
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMinimum SpO2 Value During the Case94.8 PercentStandard Deviation 3
Secondary

Minimum Systolic Blood Pressure

Minimum systolic blood pressure (mmHg) using standard operating room blood pressure cuff and monitor.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceMinimum Systolic Blood Pressure88.9 mmHGStandard Deviation 9.1
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceMinimum Systolic Blood Pressure88.1 mmHGStandard Deviation 13.7
Secondary

Number of Instances SpO2 Value < 92%

Number of instances the SpO2 drops below 92% during the procedure

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceNumber of Instances SpO2 Value < 92%.6 EpisodesStandard Deviation 0.9
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceNumber of Instances SpO2 Value < 92%.1 EpisodesStandard Deviation 0.3
Secondary

Percent Time During the Case the SpO2 is Below 92%

Percent time during the case the SpO2 is below 92% using pulse oximetry.

Time frame: Through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring AppliancePercent Time During the Case the SpO2 is Below 92%.7 Percent of TimeStandard Deviation 1.2
Group #2: Control Group, That Will Not Utilize Anti-snoring AppliancePercent Time During the Case the SpO2 is Below 92%.1 Percent of TimeStandard Deviation 0.3
Secondary

Reintubation in the Post Anesthesia Care Unit

Number of participants requiring reintubation with an endotracheal tube post surgery in the Post Anesthesia Care Unit

Time frame: 1 Day

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Group #1: Anti-snoring ApplianceReintubation in the Post Anesthesia Care Unit0 Participants
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceReintubation in the Post Anesthesia Care Unit0 Participants
Secondary

Surgical Length of Time

Surgical length of time in hours.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
Group #1: Anti-snoring ApplianceSurgical Length of Time2.5 HoursStandard Deviation 0.5
Group #2: Control Group, That Will Not Utilize Anti-snoring ApplianceSurgical Length of Time2.6 HoursStandard Deviation 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026